CD86 and neoplasm: However, tumor cells express positive costimulatory molecules, such as CD80 and CD86, at reduced levels that are insufficient to provide an effective second signal for T-cell activation, and thus, cannot effectively induce the anti-tumor immune response, generating immune tolerance instead.